{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T04:44:09Z","timestamp":1780461849955,"version":"3.54.1"},"reference-count":24,"publisher":"Oxford University Press (OUP)","license":[{"start":{"date-parts":[[2019,6,26]],"date-time":"2019-06-26T00:00:00Z","timestamp":1561507200000},"content-version":"am","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"DOI":"10.1093\/infdis\/jiz300","type":"journal-article","created":{"date-parts":[[2019,6,14]],"date-time":"2019-06-14T12:10:19Z","timestamp":1560514219000},"source":"Crossref","is-referenced-by-count":2,"title":["Evolution of Inactivated Poliovirus Vaccine Use for the Endgame and Beyond"],"prefix":"10.1093","author":[{"given":"Ananda S","family":"Bandyopadhyay","sequence":"first","affiliation":[{"name":"Bill and Melinda Gates Foundation, Seattle, Washington"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Walter A","family":"Orenstein","sequence":"additional","affiliation":[{"name":"Emory University, Atlanta, Georgia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2019,6,26]]},"reference":[{"key":"2019080115402319400_CIT0001","article-title":"Meeting of the Strategic Advisory Group of Experts on Immunization, April 2017 - conclusions and recommendations","author":"SAGE","journal-title":"Wkly Epidemiol Rec"},{"key":"2019080115402319400_CIT0002","unstructured":"Global Polio Eradication Initiative. Polio eradication & endgame strategic plan. www.polioeradication.org\/Portals. http:\/\/polioeradication.org\/wp-content\/uploads\/2016\/07\/PEESP_EN_US.pdf. Accessed 5 June 2019."},{"key":"2019080115402319400_CIT0003","doi-asserted-by":"crossref","DOI":"10.1093\/infdis\/jiz323","article-title":"Immunogenicity of intramuscular fractional dose of inactivated poliovirus vaccine","author":"Resik","year":"2019","journal-title":"J Infect Dis"},{"key":"2019080115402319400_CIT0004","doi-asserted-by":"crossref","first-page":"791","DOI":"10.2217\/fmb.15.19","article-title":"Polio vaccination: past, present and future","volume":"10","author":"Bandyopadhyay","year":"2015","journal-title":"Future Microbiol"},{"key":"2019080115402319400_CIT0005","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1016\/B978-1-4557-0090-5.00035-5","article-title":"Poliovirus vaccine - live.","volume-title":"Vaccines","author":"Sutter","year":"2013","edition":"6th"},{"key":"2019080115402319400_CIT0006","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1086\/508427","article-title":"Serologic response to inactivated poliovirus vaccine: a randomized clinical trial comparing 2 vaccination schedules in Puerto Rico","volume":"195","author":"Dayan","year":"2007","journal-title":"J Infect Dis"},{"key":"2019080115402319400_CIT0007","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1093\/cid\/ciy649","article-title":"Impact of maternal antibody on the immunogenicity of inactivated polio vaccine in infants immunized with bivalent oral polio vaccine: implications for the polio eradication endgame","volume":"67","author":"Gaensbauer","year":"2018","journal-title":"Clin Infect Dis"},{"key":"2019080115402319400_CIT0008","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/infdis\/163.1.1","article-title":"Mucosal immunity induced by enhance-potency inactivated and oral polio vaccines","volume":"163","author":"Onorato","year":"1991","journal-title":"J Infect Dis"},{"key":"2019080115402319400_CIT0009","doi-asserted-by":"crossref","first-page":"e1002599","DOI":"10.1371\/journal.ppat.1002599","article-title":"Systematic review of mucosal immunity induced by oral and inactivated poliovirus vaccines against virus shedding following oral poliovirus challenge","volume":"8","author":"Hird","year":"2012","journal-title":"PLoS Pathog"},{"key":"2019080115402319400_CIT0010","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1016\/B978-1-4557-0090-5.00034-3","article-title":"Poliovirus vaccine-inactivated.","volume-title":"Vaccines","author":"Vidor","year":"2013","edition":"6th"},{"key":"2019080115402319400_CIT0011","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/S1473-3099(15)00488-0","article-title":"Immunogenicity and safety of a novel monovalent high-dose inactivated poliovirus type 2 vaccine in infants: a comparative, observer-blind, randomised, controlled trial","volume":"16","author":"S\u00e1ez-Llorens","year":"2016","journal-title":"Lancet Infect Dis"},{"key":"2019080115402319400_CIT0012","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1093\/infdis\/jix577","article-title":"Immunogenicity of different routine poliovirus vaccination schedules: a randomized, controlled Trial in Karachi, Pakistan","volume":"217","author":"Saleem","year":"2018","journal-title":"J Infect Dis"},{"key":"2019080115402319400_CIT0013","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1093\/cid\/ciy633","article-title":"Immunogenicity of new primary immunization schedules with inactivated poliovirus vaccine and bivalent oral polio vaccine for the polio endgame: a review","volume":"67","author":"Bandyopadhyay","year":"2018","journal-title":"Clin Infect Dis"},{"key":"2019080115402319400_CIT0014","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1017\/S0022172400040389","article-title":"A study of poliovaccination in infancy: excretion following challenge with live virus by children given killed or living poliovaccine","volume":"64","author":"Henry","year":"1966","journal-title":"J Hyg (Lond)"},{"key":"2019080115402319400_CIT0015","doi-asserted-by":"crossref","first-page":"1505","DOI":"10.1016\/S0140-6736(14)60934-X","article-title":"Effect of a single inactivated poliovirus vaccine dose on intestinal immunity against poliovirus in children previously given oral vaccine: an open-label, randomised controlled trial","volume":"384","author":"John","year":"2014","journal-title":"Lancet"},{"key":"2019080115402319400_CIT0016","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1126\/science.1255006","article-title":"Polio eradication. Efficacy of inactivated poliovirus vaccine in India","volume":"345","author":"Jafari","year":"2014","journal-title":"Science"},{"key":"2019080115402319400_CIT0017","doi-asserted-by":"crossref","first-page":"1876","DOI":"10.1093\/infdis\/jiy389","article-title":"Boosting of mucosal immunity after fractional-dose inactivated poliovirus vaccine","volume":"218","author":"Gamage","year":"2018","journal-title":"J Infect Dis"},{"key":"2019080115402319400_CIT0018","first-page":"173","article-title":"Limitation of fecal and pharyngeal poliovirus excretion in Salk-vaccinated children. A family study during a type 1 poliomyelitis epidemic","volume":"76","author":"Marine","year":"1962","journal-title":"Am J Hyg"},{"key":"2019080115402319400_CIT0019","doi-asserted-by":"crossref","first-page":"20586","DOI":"10.2807\/1560-7917.ES2013.18.38.20586","article-title":"Insidious reintroduction of wild poliovirus into Israel","volume":"18","author":"Anis","year":"2013","journal-title":"Euro Surveill"},{"key":"2019080115402319400_CIT0020","doi-asserted-by":"crossref","first-page":"S347","DOI":"10.1093\/infdis\/jiu060","article-title":"Switch from oral to inactivated poliovirus vaccine in Yogyakarta Province, Indonesia: summary of coverage, immunity, and environmental surveillance","volume":"210","author":"Wahjuhono","year":"2014","journal-title":"J Infect Dis"},{"key":"2019080115402319400_CIT0021","doi-asserted-by":"crossref","first-page":"258","DOI":"10.3201\/eid2302.161210","article-title":"Estimated effect of inactivated poliovirus vaccine campaigns, Nigeria and Pakistan, January 2014\u2013April 2016","volume":"23","author":"Shirreff","year":"2017","journal-title":"Emerg Infect Dis"},{"key":"2019080115402319400_CIT0022","doi-asserted-by":"crossref","first-page":"2113","DOI":"10.3201\/eid2411.180050","article-title":"Effect of inactivated poliovirus vaccine campaigns, Pakistan, 2014-2017","volume":"24","author":"Grassly","year":"2018","journal-title":"Emerg Infect Dis"},{"key":"2019080115402319400_CIT0023","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.vaccine.2011.11.018","article-title":"Intradermal fractional dose inactivated polio vaccine: a review of the literature","volume":"30","author":"Nelson","year":"2012","journal-title":"Vaccine"},{"key":"2019080115402319400_CIT0024","doi-asserted-by":"crossref","first-page":"3392","DOI":"10.1016\/j.vaccine.2012.11.021","article-title":"Intradermal delivery for vaccine dose sparing: overview of current issues","volume":"31","author":"Zehrung","year":"2013","journal-title":"Vaccine"}],"container-title":["The Journal of Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/jid\/advance-article-pdf\/doi\/10.1093\/infdis\/jiz300\/29029803\/jiz300.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"}],"deposited":{"date-parts":[[2019,8,1]],"date-time":"2019-08-01T19:40:35Z","timestamp":1564688435000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jid\/advance-article\/doi\/10.1093\/infdis\/jiz300\/5523740"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,6,26]]},"references-count":24,"URL":"https:\/\/doi.org\/10.1093\/infdis\/jiz300","relation":{},"ISSN":["0022-1899","1537-6613"],"issn-type":[{"value":"0022-1899","type":"print"},{"value":"1537-6613","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,6,26]]},"article-number":"jiz300"}}